Free MPJE Practice Test by State 2026: 5,000+ Pharmacy Law Questions

Your Pharmacy License Is One Exam Away

You survived pharmacy school. You conquered the NAPLEX. Now there is one final barrier between you and your pharmacist license: the Multistate Pharmacy Jurisprudence Examination (MPJE). This computer-adaptive test of federal and state pharmacy law trips up roughly one in four first-time test-takers nationally, and in some states the failure rate is even higher. Failing means a 30-day waiting period, another $270 fee, and weeks of lost earning potential in a career that pays a median salary of $140,920 per year (BLS OEWS, May 2025).

The good news? Pharmacy law is learnable, and the right practice questions make all the difference. This guide gives you everything you need: the exam format, a complete state-by-state directory of free practice tests, a content breakdown of every tested domain, 10 sample questions with explained answers, a week-by-week study plan, and a head-to-head comparison of free vs. paid prep resources.

Why pharmacists earn what they do: The BLS projects 5% employment growth for pharmacists from 2024 to 2034, with about 14,200 openings per year. Specialized settings such as hospital and ambulatory-care pharmacy often pay above the national median. Every week you delay licensure is a week of lost income at those rates.

---

Start Your FREE MPJE Practice Test

Take FREE MPJE Practice TestPractice questions with detailed explanations

Over 5,000 pharmacy law practice questions covering federal and state-specific regulations. No signup. No credit card. 100% FREE.

---

MPJE Exam Format: Everything You Need to Know

2026 Update: The Uniform MPJE (UMPJE) Is Here

NABP launched the Uniform MPJE (UMPJE) for early adopter boards on April 1, 2026 (Arizona, Iowa, Kansas, North Carolina, Ohio, and Rhode Island), with additional jurisdictions joining June-July 2026 (Florida, Maryland, Montana, Nebraska, West Virginia, and Washington). As of July 2026, 12 jurisdictions administer the UMPJE. The exam keeps the same structure as the traditional MPJE --- 120 questions (100 scored + 20 pretest), 2.5 hours, pass/fail scoring --- but tests pharmacy-law principles common to all jurisdictions plus federal law, so one exam result can transfer to any other participating state for a $105 transfer fee. The base UMPJE cost is $450 ($100 application + $350 exam fee) for your first jurisdiction. Some boards still layer on a state-specific "plus module" alongside the UMPJE --- for example, Maryland requires a state competency assessment and Ohio requires a pharmacy law course.

Key difference: The traditional MPJE is state-specific (you take a different version for each state, and the score does not transfer). The UMPJE lets you demonstrate competency once and transfer that result to every other participating state for a $105 fee, cutting the time (though not necessarily the cost) of qualifying in multiple states.

---

Free MPJE Practice Tests by State

Find your state below and start practicing with free pharmacy law questions tailored to your jurisdiction. Each practice test covers both federal pharmacy law and your state's specific regulations.

---

MPJE Content Breakdown: What the Exam Tests

NABP's current MPJE Competency Statements organize the exam into four content areas (this blueprint applies through February 28, 2027; NABP's updated MPJE Content Outline takes effect for exams administered on or after March 1, 2027). Understanding the weight of each area is critical for prioritizing your study time.

Area 1: Licensure/Personnel (22%)

• Pharmacist and non-pharmacist personnel responsibilities --- qualifications, scope of duties, and practice limitations for pharmacists-in-charge and staff pharmacists; qualifications and restrictions for pharmacy technicians, including pharmacist-to-technician ratios and prohibited (non-delegable) tasks.

• Licensure, registration, and certification --- initial licensure requirements, reciprocity/license transfer, renewal requirements, continuing education mandates, intern/extern supervision rules, and disciplinary action classifications and processes (including impaired-practitioner programs). Each state sets its own CE hours and topic requirements.

Area 2: Pharmacist Practice (33% --- the largest area)

The single biggest domain, covering the pharmacist's direct role in prescription and drug therapy decisions.

• Prescription/drug order requirements --- elements of a valid prescription, prescriber scope of authority and limitations, controlled vs. non-controlled prescription requirements, refill authorization and limits. Expect scenario-based questions on schedule-specific rules (e.g., C-II vs. C-III refill limits, emergency dispensing of C-II drugs).

• Drug administration participation --- pharmacist authority to administer vaccines and other injectable medications, and any required training or protocol agreements.

• Counseling requirements --- OBRA '90 counseling requirements, state-specific counseling mandates, and documentation of counseling (or of offering to counsel).

• Drug return/reuse regulations --- when returned or unused medications may (or may not) be redispensed.

• Pharmacy practice regulations --- quality and public health safety obligations, plus protecting patient and health record confidentiality (HIPAA privacy and security rules, Notice of Privacy Practices, minimum necessary standard, patient access to records).

Area 3: Dispensing Requirements (24%)

• Determining legitimate medical purpose --- the corresponding responsibility doctrine and red flags for diversion.

• Prescription transfers between pharmacies --- rules for controlled vs. non-controlled substances.

• Prospective drug utilization review and PMP reporting/access --- checking for interactions, duplicate therapy, and querying your state's prescription monitoring program.

• Exceptions to dispensing/refilling --- emergency fills, disaster/emergency declarations, and partial fills.

• Drug labeling and packaging requirements --- label requirements (federal vs. state), auxiliary labels, beyond-use dating, and child-resistant packaging under the Poison Prevention Packaging Act (and its specific exemptions).

• Conditions prohibiting dispensing --- forged or altered prescriptions, expired authority, and other red-flag scenarios.

• Non-prescription product distribution --- behind-the-counter sales, pseudoephedrine/Combat Methamphetamine Epidemic Act limits, and other restricted non-prescription drugs.

Area 4: Pharmacy Operations (21%)

• Recordkeeping and reporting --- prescription record retention (most states require 2-5 years), controlled substance inventory requirements (biennial, with exact counts for Schedule II and estimated counts for III-V unless a container holds more than 1,000 units), DEA Form 222 (C-II ordering), DEA Form 41 (destruction), and DEA Form 106 (theft/loss reporting).

• Hazardous and non-hazardous drug handling and disposal --- storage, handling, and disposal rules, including DEA take-back and reverse-distribution requirements.

• Product selection --- generic substitution laws, Orange Book ratings (AB-rated), narrow therapeutic index drugs, "Dispense as Written" (DAW) codes, and patient notification requirements for substitution.

• Compounding --- USP <795> (nonsterile), USP <797> (sterile), beyond-use dates for compounded preparations, ingredient sourcing, and compounding recordkeeping.

• Centralized/central-fill prescription processing and practice setting registration, licensure, certification, and permitting --- pharmacy permit types (community, institutional, nuclear, etc.), DEA registration (Form 224), change-of-ownership procedures, and inspection protocols.

Threaded throughout all four areas

A few concepts show up across every domain rather than in one isolated section, so do not skip them: the roles of federal regulatory agencies (FDA drug approval/recalls/MedWatch, DEA controlled-substance enforcement, CMS Medicare/Medicaid billing, OSHA workplace safety), the authority and disciplinary process of state Boards of Pharmacy, and the legal hierarchy rule --- federal law sets the floor, state law can be stricter but never more lenient, and when the two conflict, the stricter law governs.

---

10 MPJE Sample Questions with Answers

Test your knowledge with these representative MPJE practice questions. Each includes a detailed explanation.

Question 1: A pharmacist receives a prescription for hydrocodone/acetaminophen (Schedule II) with 3 refills authorized. What is the correct action?

Answer: Dispense the original prescription with zero refills. Schedule II controlled substances cannot be refilled under federal law, regardless of what the prescriber writes. The pharmacist should contact the prescriber if ongoing therapy is needed to arrange new prescriptions.

---

Question 2: Under HIPAA, which of the following does NOT require patient authorization for disclosure of PHI?

A) Marketing communications from the pharmacy B) Treatment purposes between healthcare providers C) Sale of patient data to a third party D) Fundraising solicitations

Answer: B --- Treatment, payment, and healthcare operations (TPO) are the three permitted uses of PHI without patient authorization. Marketing, sale of data, and most research uses require written authorization.

---

Question 3: A pharmacy technician in your state asks if they can accept a new verbal prescription from a physician. Under federal law, who can receive a verbal prescription?

Answer: Federal law does not specifically prohibit technicians from receiving verbal prescriptions; however, most states restrict this to pharmacists or pharmacy interns under direct pharmacist supervision. You must follow your state's specific rule, and when the state rule is stricter than federal, the state rule governs.

---

Question 4: How often must a pharmacy conduct a controlled substance inventory, and what does it require?

Answer: A pharmacy must conduct a complete controlled substance inventory at least every two years (biennially) per DEA regulations. Schedule II substances require an exact count, while Schedules III-V allow an estimated count unless the container holds more than 1,000 units, in which case an exact count is required. The inventory must include date, time, drug name, dosage form, strength, and quantity.

---

Question 5: A pharmacist discovers a prescription forged by a patient. What are the pharmacist's legal obligations?

Answer: The pharmacist must not dispense the prescription. Federal law requires reporting suspected forgeries to the DEA. Most states also require notification of local law enforcement and the state board of pharmacy. The pharmacist should document the incident and retain the forged prescription as evidence.

---

Question 6: Under the Poison Prevention Packaging Act, which of the following medications is EXEMPT from child-resistant packaging?

A) Amoxicillin suspension B) Sublingual nitroglycerin C) Lisinopril tablets D) Metformin tablets

Answer: B --- Sublingual nitroglycerin is one of the specific exemptions from child-resistant packaging, along with certain oral contraceptives in manufacturer packaging, sublingual isosorbide dinitrate (10 mg and under), and a few others. Patients may also request non-safety caps with a signed waiver.

---

Question 7: A prescriber calls in a prescription for 120 tramadol 50mg tablets. What schedule is tramadol classified under federal law, and what are the refill limitations?

Answer: Tramadol is classified as Schedule IV under federal law. Schedule III-V medications may be refilled up to 5 times within 6 months from the date of issuance. After 5 refills or 6 months (whichever comes first), a new prescription is required.

---

Question 8: What is the "corresponding responsibility" doctrine, and how does it apply to pharmacists?

Answer: The corresponding responsibility doctrine means that a pharmacist shares legal responsibility with the prescriber to ensure a controlled substance prescription is issued for a legitimate medical purpose. A pharmacist cannot simply fill every prescription presented --- they must use professional judgment to identify red flags (excessive quantities, early refills, cash payment patterns, long distances traveled) and refuse to fill prescriptions they believe are not for a legitimate medical purpose.

---

Question 9: A patient presents a prescription from a nurse practitioner. Which factors must the pharmacist verify before dispensing?

Answer: The pharmacist must verify that the NP has prescriptive authority in the state where the prescription is written, the prescription is within the NP's scope of practice, any required collaborative or supervisory agreement is in place (varies by state), and the NP's DEA number is valid if the prescription is for a controlled substance. The specific prescriptive authority of NPs varies significantly by state.

---

Question 10: Under DSCSA (Drug Supply Chain Security Act), what are a pharmacy's obligations for verifying drug products?

Answer: The DSCSA requires pharmacies to maintain transaction documentation (transaction information, transaction history, and transaction statement --- the "3 Ts") for each drug product received. Pharmacies must verify suspect and illegitimate products, quarantine illegitimate products, report illegitimate products to the FDA and trading partners, and respond to verification requests within 24 hours. Full electronic interoperable tracing requirements went into effect in November 2024.

---

How to Prepare: 6-Week MPJE Study Plan

Weeks 1-2: Build Your Federal Law Foundation

• Read the Controlled Substances Act (CSA) focusing on scheduling, prescribing, dispensing, and record-keeping requirements
• Study HIPAA privacy and security rules
• Review OBRA '90 counseling requirements
• Review the Poison Prevention Packaging Act exemptions
• Complete 50 federal law practice questions daily on OpenExamPrep

Week 3: Master Your State's Practice Act

• Download and read your state's Pharmacy Practice Act cover to cover
• Create a comparison chart of state vs. federal law where they differ
• Focus on technician ratios, CE requirements, and controlled substance rules
• Complete 50 state-specific practice questions daily

Week 4: Deep-Dive into Controlled Substances

• Study DEA forms: 222 (C-II ordering), 224 (registration), 41 (destruction), 106 (theft/loss)
• Master prescription transfer rules for controlled vs. non-controlled substances
• Review PDMP requirements for your state
• Complete 75 mixed practice questions daily

Week 5: Operational and Administrative Law

• Study pharmacy permit types, inspection procedures, and change-of-ownership rules
• Review disciplinary procedures, grounds for board action, and penalty structures
• Study DSCSA track-and-trace requirements
• Complete 100 mixed practice questions daily under timed conditions

Week 6: Full-Length Practice Exams and Review

• Take 2-3 full-length timed practice exams (120 questions in 2.5 hours)
• Review every question you missed and identify pattern weaknesses
• Re-read state law sections you scored lowest on
• Focus final two days on your weakest areas
• Schedule exam for the end of Week 6 or beginning of Week 7

---

7 Study Tips That Actually Work

1. "Stricter law applies" is your golden rule --- When federal and state law conflict, the stricter of the two governs. This principle answers roughly 15-20% of MPJE questions. If your state allows 72-hour emergency C-II fills but federal law caps at 72 hours, the limiting factor applies. Build a comparison table and memorize the differences.

2. Memorize the numbers --- The MPJE loves numerical details: prescription validity periods (6 months for C-III through C-V, no refills for C-II), record retention (usually 2-5 years by state), technician ratios, CE hours, and beyond-use dates. Create flashcards specifically for numbers.

3. Study DEA forms by function, not number --- Instead of memorizing "Form 222," remember "ordering Schedule II" and link it to the form. Form 222 = ordering C-II. Form 41 = destroying controlled substances. Form 106 = reporting theft or loss. Form 224 = DEA registration.

4. Read your state's pharmacy practice act at least twice --- Once for the big picture (who can do what), once for the details (specific numbers, deadlines, exceptions). The second read always reveals things you missed.

5. Practice under adaptive conditions --- The MPJE is computer-adaptive, meaning you cannot go back to previous questions. Practice answering questions one at a time without reviewing. This builds the decision-confidence you need on test day.

6. Focus on the "why" behind each law --- Understanding legislative intent (patient safety, preventing diversion, ensuring access) helps you reason through questions you have never seen. The MPJE tests application of law, not just memorization.

7. Take at least two full-length timed practice exams --- Simulate real conditions: 120 questions, 150 minutes, no breaks, no references. Review every missed question. Your practice exam scores should trend upward each time.

---

MPJE vs. CPJE: California's Different Exam

California does not use the MPJE. Instead, California administers the CPJE (California Pharmacy Jurisprudence Examination), which is widely regarded as one of the toughest pharmacy law exams in the country.

CPJE Practice TestPractice questions with detailed explanations

---

Free vs. Paid MPJE Prep Resources Compared

---

Why OpenExamPrep for MPJE Prep

• Completely free --- no signup, no credit card, no trial period that expires
• 5,000+ pharmacy law questions covering every MPJE competency area
• State-specific practice tests for all 50 states plus DC and the CPJE
• AI-powered tutor that explains concepts in plain language and adapts to your weak areas
• Updated for 2026 --- includes UMPJE content for all 12 participating states
• Instant access --- start practicing right now, no downloads or accounts needed
• Mobile optimized --- practice anywhere on your phone, tablet, or computer

---

Frequently Asked Questions